Healthcare >> CEO Interviews >> June 23, 2003

Edward Lanphier – Sangamo Biosciences Inc (sgmo)

EDWARD LANPHIER founded Sangamo BioSciences, Inc., in 1995, and has served as President, CEO and a member of the Board of Directors since its inception. He has over 25 years' experience in the pharmaceutical and biotechnology industry. From 1992 to 1997, he was associated with Somatix Therapy Corporation, a gene therapy company, in positions including Executive Vice President, Commercial Development and CFO. Prior to Somatix, Mr. Lanphier was President and CEO of BioGrowth, Inc. From 1986 to 1987, he was Vice President of Corporate Development at Biotherapeutics, Inc., a position that he had previously held at Synergen, Inc. With Eli Lilly and Company, he was part of the strategic business planning-biotechnology group. Mr. Lanphier serves on the Board of Directors of the Biotechnology Institute. Profile
TWST: We spoke to Sangamo Biosciences about a year ago. What has

gone on over the past year that investors should focus on?

Mr. Lanphier: The big events of the last year have really been

the